1[1]Isolauri E. Probiotics in human disease. Am J Clin Nutr, 2001, 73: 1142S～1146S.
2[2]Saavedra JM. Clinical applications of probiotic agents. Am J Clin Nutr, 2001, 73: 1147S1151S.
3[3]Bengmark S. Colonic food: pre- and probiotics.Am J Gastroenterol, 2000, 95 (1 Suppl): S5～S7.
4[4]Saavedra J. Probiotics and infectious diarrhea.Am J Gastroenterol, 2000, 95 (1 Suppl): S16～S18.
5[5]Schultz M, Sartor RB. Probiotics and inflammatory bowel diseases. Am J Gastroenterol, 2000, 95(1 Suppl): S19～S21.
6[6]Kruis W, Schutz E, Fric P, Fixa B, Judmaier G,Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment Pharmacol Ther, 1997, 11: 853～858.
7[7]Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet, 1999,354: 635～639.
8[8]Mitsuyama K, Saiki T, Kanauchi O, Iwanaga T,Tomiyasu N, Nishiyama T, Tateishi H, Shirachi A, Ide M, Suzuki A, Noguchi K, Ikeda H, Toyonaga A, Sata M. Treatment of ulcerative colitis with germinated barley foodstuff feeding: a pilot study.Aliment Pharmacol Ther, 1998, 12: 1225～1230.
9[9]Guslandi M, Mezzi G, Sorghi M, Testoni PA. Sac-charomyces boulardii in maintenance treatmentof Crohn's disease. Dig Dis Sci, 2000, 45: 1462～1464.
10[10]Armuzzi A, Cremonini F, Bartolozzi F, CanducciF, Candelli M, Ojetti V, Cammarota G, Anti M,De Lorenzo A, Pola P, Gasbarrini G, GasbarriniA. The effect of oral administration of Lactobacil-lus GG on antibiotic-associated gastrointestinalside-effects during Helicobacter pylori eradicationtherapy. Aliment Pharmacol Ther, 2001, 15: 163～169.
